← Back to News

INDVFool - Investing News·May 30, 2026 at 04:01 PM

What to Know About This Fund's $74.8 Million Indivior Sale

What to Know About This Fund's $74.8 Million Indivior Sale

Indivior develops buprenorphine-based treatments for opioid dependence, serving markets in the US, UK, and worldwide.

Source: Fool - Investing News

INDVIndivior Pharmaceuticals Inc

$35.51 – $36.61

View INDVdetails →

More INDV News

Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%

Fool - Investing News·9h ago